Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 558

1.

Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?

Vordermark D, Brown JM.

Strahlenther Onkol. 2003 Dec;179(12):801-11. Review.

PMID:
14652668
2.

Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking?

Mayer A, Höckel M, Vaupel P.

Strahlenther Onkol. 2006 Sep;182(9):501-10. Review.

PMID:
16944371
3.

Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.

Dellas K, Bache M, Pigorsch SU, Taubert H, Kappler M, Holzapfel D, Zorn E, Holzhausen HJ, Haensgen G.

Strahlenther Onkol. 2008 Mar;184(3):169-74. doi: 10.1007/s00066-008-1764-z.

PMID:
18330514
4.
5.

Hypoxic sensitizer and cytotoxin for head and neck cancer.

Lee DJ, Moini M, Giuliano J, Westra WH.

Ann Acad Med Singapore. 1996 May;25(3):397-404. Review.

PMID:
8876907
6.

Hypoxia in head and neck cancer: how much, how important?

Janssen HL, Haustermans KM, Balm AJ, Begg AC.

Head Neck. 2005 Jul;27(7):622-38. Review.

PMID:
15952198
8.

Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review.

Hoogsteen IJ, Marres HA, Bussink J, van der Kogel AJ, Kaanders JH.

Head Neck. 2007 Jun;29(6):591-604. Review.

PMID:
17252597
9.

Cell type-specific association of hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein accumulation and radiobiologic tumor hypoxia.

Vordermark D, Katzer A, Baier K, Kraft P, Flentje M.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1242-50.

PMID:
15001269
10.

Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.

Bachtiary B, Schindl M, Pötter R, Dreier B, Knocke TH, Hainfellner JA, Horvat R, Birner P.

Clin Cancer Res. 2003 Jun;9(6):2234-40.

11.

Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.

Bache M, Reddemann R, Said HM, Holzhausen HJ, Taubert H, Becker A, Kuhnt T, Hänsgen G, Dunst J, Vordermark D.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1481-7. Epub 2006 Oct 23.

PMID:
17056190
12.

Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.

Ishikawa H, Sakurai H, Hasegawa M, Mitsuhashi N, Takahashi M, Masuda N, Nakajima M, Kitamoto Y, Saitoh J, Nakano T.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):513-21.

PMID:
15380586
13.

Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.

Jankovic B, Aquino-Parsons C, Raleigh JA, Stanbridge EJ, Durand RE, Banath JP, MacPhail SH, Olive PL.

Cytometry B Clin Cytom. 2006 Mar;70(2):45-55.

14.

Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.

Jokilehto T, Rantanen K, Luukkaa M, Heikkinen P, Grenman R, Minn H, Kronqvist P, Jaakkola PM.

Clin Cancer Res. 2006 Feb 15;12(4):1080-7.

15.
16.

A clinical study of hypoxia using endogenous hypoxic markers and polarographic oxygen electrodes.

Sakata K, Someya M, Nagakura H, Nakata K, Oouchi A, Hareyama M, Satoh M.

Strahlenther Onkol. 2006 Sep;182(9):511-7.

PMID:
16944372
17.

Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.

De Ridder M, Van Esch G, Engels B, Verovski V, Storme G.

Bull Cancer. 2008 Mar;95(3):282-91. doi: 10.1684/bdc.2008.0592. Review.

18.

Hypoxia in cancer: significance and impact on clinical outcome.

Vaupel P, Mayer A.

Cancer Metastasis Rev. 2007 Jun;26(2):225-39. Review.

PMID:
17440684
19.

Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy.

Burri P, Djonov V, Aebersold DM, Lindel K, Studer U, Altermatt HJ, Mazzucchelli L, Greiner RH, Gruber G.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):494-501.

PMID:
12738326
20.

Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.

Hutchison GJ, Valentine HR, Loncaster JA, Davidson SE, Hunter RD, Roberts SA, Harris AL, Stratford IJ, Price PM, West CM.

Clin Cancer Res. 2004 Dec 15;10(24):8405-12.

Supplemental Content

Support Center